PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
July 16, 2020Molecules107 citationsOpen Access

Relevant Applications of Generative Adversarial Networks in Drug Design and Discovery: Molecular De Novo Design, Dimensionality Reduction, and De Novo Peptide and Protein Design

ELEugene LinCLChieh‐Hsin LinHLHsien‐Yuan Lane

Key Points

Key points are not available for this paper at this time.

Abstract

peptide and protein design using GAN frameworks. Moreover, we outline the limitations in regard to the previous drug design and discovery studies using GAN models. Finally, we present a discussion of directions and challenges for future research.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Lin et al. (2020) studied this question.

synapsesocial.com/papers/69ff9bd6b124fe58198587e9https://doi.org/10.3390/molecules25143250
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Machine learning methods in chemoinformatics2014 · 486 citations
  2. 2Wisp1 is a circulating factor that stimulates proliferation of adult mouse and human beta cells2020 · 57 citations
  3. 3Planning chemical syntheses with deep neural networks and symbolic AI2018 · 1,955 citations
  4. 4Mol-CycleGAN: a generative model for molecular optimization2020 · 248 citations
  5. 5Reinforced Adversarial Neural Computer for de Novo Molecular Design2018 · 394 citations